✦ LIBER ✦

532 POOR ADHERENCE TO PEGYLATED-INTERFERON AND RIBAVIRIN IS A MAJOR CONCERN IN THE TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION: EVIDENCE FROM THE RECOLT-C GROUP

✍ Scribed by D. Di Paolo; F.R. Ponziani; S. Fagiuoli; R. Viganò; R.M. Iemmolo; M.F. Ponato; M. Rendina; M. Cescon; P. Toniutto; L. Miglioresi; E. De Martin; M. Merli; G. Tisone; M. Angelico

Book ID: 117379677
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 42 KB
Volume: 54
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(11)60534-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated interferon-alpha2a/ribavirin t

Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation

✍ S. Dinges; I. Morard; M. Heim; J.-F. Dufour; B. Müllhaupt; E. Giostra; P.-A. Cla 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

Combined treatment with pegylated interf

Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation

✍ Lluís Castells; Víctor Vargas; Helena Allende; Itxarone Bilbao; José Luis Lázaro 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 136 KB

The Effect and Safety of the Treatment o

The Effect and Safety of the Treatment of Recurrent Hepatitis C Infection After Orthotopic Liver Transplantation With Pegylated Interferon α2b and Ribavirin

✍ A. Perrakis; S. Yedibela; S. Schuhmann; R. Croner; V. Schellerer; R. Demir; W. H 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Prediction of nonSVR to therapy with peg

Prediction of nonSVR to therapy with pegylated interferon-α2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment

✍ E. Lukasiewicz; M. Gorfine; L. S. Freedman; J.-M. Pawlotsky; S. W. Schalm; C. Fe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB